Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$262K Hold
1,800
– – 0.12% 51
2026
Q2
$231K Hold
1,800
– – 0.11% 53
2026
Q1
$217K Buy
+1,800
New +$208K 0.11% 56
2025
Q1
– Sell
-2,000
Closed -$199K – 51
2024
Q4
$199K Hold
2,000
– – 0.14% 42
2024
Q3
$227K Hold
2,000
– – 0.15% 41
2024
Q2
$248K Hold
2,000
– – 0.18% 42
2024
Q1
$264K Hold
2,000
– – 0.2% 43
2023
Q4
$218K Hold
2,000
– – 0.18% 44
2023
Q3
$206K Hold
2,000
– – 0.17% 45
2023
Q2
$231K Hold
2,000
– – 0.19% 44
2023
Q1
$213K Hold
2,000
– – 0.19% 44
2022
Q4
$222K Buy
+2,000
New +$204K 0.21% 46

Other funds holding MRK

Gouws Capital LLC's MRK Position: Q3 2026 in Review

Gouws Capital LLC held its Merck (MRK) position steady in Q3 2026 at 1,800 shares worth $262K. The position accounts for 0.12% of the portfolio, ranked #51.

Gouws Capital LLC first reported a position in MRK in Q4 2022 and has held it in 12 quarters since. The position peaked at $264K in Q1 2024. 203 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Gouws Capital LLC held 1,800 shares of Merck worth $262K as of Q3 2026.
  • Gouws Capital LLC left its Merck share count unchanged in Q3 2026.
  • Merck made up 0.12% of Gouws Capital LLC's portfolio in Q3 2026, its #51 holding.
  • Gouws Capital LLC first reported a position in Merck in Q4 2022 and has held it in 12 quarters since.
  • Gouws Capital LLC's Merck position peaked at $264K in Q1 2024.
  • 203 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Gouws Capital LLC's 13F filing for Q3 2026, filed 9 Oct 2026.